Task Order 5: The Interventional Agent Development Services Program

Sri International, Menlo Park CA

Investigators

Abstract

The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents. Services include: lead identification and development; chemistry and manufacturing; in vitro and in vivo preclinical safety, toxicology and biokinetics; and preclinical development, planning and evaluation. This task focuses on feasibility assessments and product development planning.